InvestorsHub Logo
Followers 30
Posts 9883
Boards Moderated 0
Alias Born 01/20/2018

Re: Hawk05 post# 184439

Thursday, 06/20/2019 5:48:31 AM

Thursday, June 20, 2019 5:48:31 AM

Post# of 330224
As you say Hawk..."closed deals and sales" will be the primary pps movers. It will be interesting to see if RecoveryRX passage by the FDA has any impact. That one is a blockbuster. Dr. Sree Koneru believes it holds Standard of Care potential. As I understand it Mundipharma reps will be able push RecoveryRX abroad unimpeded. Nice to know should the FDA prove uncooperative. Go Biel$$$